ALIMTA (pemetrexed for injection)

ALIMTA (pemetrexed for injection)

Composition : PEMETREXED-500MG
Description : ALIMTA INJ – 500MG
Route Of Administration : PARENTERAL
Pack : 1

ALIMTA® (pemetrexed for injection) is approved by the FDA in combination with KEYTRUDA® (pembrolizumab) (an immunotherapy) and platinum chemotherapy (carboplatin or cisplatin, two other chemotherapy drugs) as the first treatment for nonsquamous non-small cell lung cancer (NSCLC) that has spread with no abnormal EGFR or ALK gene.*


ALIMTA (pemetrexed for injection)

Pemetrexed is a cancer medicine that interferes with the growth and spread of cancer cells in the body. Pemetrexed is used to treat non-small cell lung cancer, or malignant pleural mesothelioma (a form of lung cancer associated with exposure to asbestos). Pemetrexed is sometimes used in combination with other cancer medicines.

For Injection: 100 mg or 500 mg lyophilized powder in single-dose vial


Pharma Services and Drug Inquiries

Our Pharma Division deals only with the best, GMP certified generics and branded medication for the export market. All our products are supported by strict adherence to quality and analysis certification.

Please note for the minimum order for Exports is of US$ 3000. All orders will be subject to courier charges and supplies are normally dispatched through internationally accredited courier services.

Complete the form below to receive the no-obligation price quote.